11/16/09 HC Reform Update by Mark Sanna: The pharmaceutical industry’s trade group, Pharmaceutical Research and Manufacturers of America, announced that they will oppose health care legislation if the White House and Congress reduce a proposed 12-year monopoly on biologic drugs. The group includes the CEOs of Pfizer, Merck, Bristol-Myers Squibb and other pharmaceutical companies